Tierney David S
- SEC CIK
- 0001292636
No open-market purchases or sales filed in the past year.
Current role at each company
- CPRX Catalyst Pharmaceuticals, Inc.Directoras of Jul 17, 2026
- ZVRA Zevra Therapeutics, Inc.Directoras of Mar 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tierney David S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CPRX Catalyst Pharmaceuticals, Inc.
Director8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 (view filing) | Aug 27 | 1 day | Tierney David SDirector | SSaleCommon Stock, par value $0.001 per share | −26.0K | $20.20 | −$525.2K | −6.4%379.6K after | |
| Aug 23, 2024 (view filing) | Aug 21 | 2 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −15.0K | $20.10 | −$301.5K | −4.1%348.9K after | |
| Apr 10, 2024 (view filing) | Apr 8 | 2 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −25.0K | $15.68 | −$392.0K | −6.7%348.9K after | |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −50.0K | $13.33 | −$666.5K | −13.0%333.5K after | |
| Apr 7, 2023 (view filing) | Apr 5 | 2 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −30.0K | $16.83 | −$504.9K | −8.7%313.5K after | |
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −20.0K | $14.16 | −$283.2K | −6.1%308.2K after | |
| May 24, 2022 (view filing) | May 20 | 4 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −20.0K | – | – | −6.1%308.2K after | |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −50.0K | $6.08 | −$304.0K | −14.0%306.9K after |
ZVRA Zevra Therapeutics, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2023 (view filing) | Mar 9 | 4 days | Tierney David SDirector | PPurchase | +5.00K | $4.15 | +$20.8K | +85.7%10.8K after | |
| May 26, 2022 (view filing) | May 25 | 1 day | Tierney David SDirector | PPurchase | +2.00K | $4.39 | +$8.78K | +52.2%5.83K after | |
| Nov 30, 2021 (view filing) | Nov 30 | Same day | Tierney David SDirector | PPurchase | +2.00K | $7.79 | +$15.6K | +109.0%3.83K after |